Olympus expands in cancer tech with $270M buy of BioProtect
BioProtect's balloon spacer device separates the prostate from other structures during cancer radiation.
Sources
- news.google.com 4790
- South China Morning Post 55
- hrexecutive.com 17
- U.S. FDA 15
- japantoday.com 14
- afro.who.int 12
- World Health Organization 12
- hrdive.com 11
- MedTech Dive 10
- Nature 7
- hongkongfp.com 4
- nih.gov 3
- 8world.com 0
- asia.nikkei.com 0
- asiaone.com 0
- bangkokpost.com 0
- CNA 0
- Endpoints News 0
- english.kyodonews.net 0
- feeds.bbci.co.uk 0
- fiercehealthcare.com 0
- gov.uk 0
- hsa.gov.sg 0
- japantimes.co.jp 0
- jtimes.jp 0
- koreaherald.com 0
- moh.gov.sg 0
- ntu.edu.sg 0
- nus.edu.sg 0
- singhealth.com.sg 0
- The Business Times 0
- The Straits Times 0
- thehindubusinessline.com 0
- thestandard.com.hk 0
- timesofindia.indiatimes.com 0
- TODAY Online 0
- wwwnc.cdc.gov 0
- news.google.com 4790
- South China Morning Post 55
- hrexecutive.com 17
- U.S. FDA 15
- japantoday.com 14
- afro.who.int 12
- World Health Organization 12
- hrdive.com 11
- MedTech Dive 10
- Nature 7
- hongkongfp.com 4
- nih.gov 3
- 8world.com 0
- asia.nikkei.com 0
- asiaone.com 0
- bangkokpost.com 0
- CNA 0
- Endpoints News 0
- english.kyodonews.net 0
- feeds.bbci.co.uk 0
- fiercehealthcare.com 0
- gov.uk 0
- hsa.gov.sg 0
- japantimes.co.jp 0
- jtimes.jp 0
- koreaherald.com 0
- moh.gov.sg 0
- ntu.edu.sg 0
- nus.edu.sg 0
- singhealth.com.sg 0
- The Business Times 0
- The Straits Times 0
- thehindubusinessline.com 0
- thestandard.com.hk 0
- timesofindia.indiatimes.com 0
- TODAY Online 0
- wwwnc.cdc.gov 0
Hong Kong-based Jardine Matheson buys Australian diagnostic group I-MED for US$2.4 billion
Jardine Matheson, an investment company headquartered in Hong Kong, announced on Monday the A$3.4 billion (US$2.4 billion) acquisition of the entire stake of an Australian diagnostic and teleradiology group. T…
Natera wins FDA approval for companion diagnostic
The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of recurrence.